
SwanBio is now part of Spur Therapeutics! Our potential first-in-class gene therapy candidate for #adrenomyeloneuropathy (#AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com and follow our progress @spurtherapeutx






















